in this issue
Markets :: Fine Chemicals/Biotech :: Industrial Biotech
Myriant withdraws IPO
10:19 AM MST | January 9, 2014 | Rebecca Coons
Biochemical firm Myriant (Quincy, MA) has withdrawn its plans for a $125-million initial public offering, according to an SEC filing dated 8 January. The move comes shortly after PTT Global Chemical (PTT) increased its stake in Myriant by nearly 60%. PTT announced on 23 December 2013 that it had bought 6,049,443 Myriant shares for $6.7 million, increasing its stake from 47.18% to 72.62%. PTT announced yesterday that it had purchased an additional 3,406,569 shares—increasing its stake to 84.77%—and that it reduced its issued and outstanding capital by...
This information is only available to Chemical Week subscribers.
Forgot your user ID or password?
Not an IHS Chemical Week member yet?
Here's why you should be:
100% Satisfaction Guarantee